Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 152

Sort by

Sort Order Select

Journal Articles

CAR T cells in autoimmunity: game changer or stepping stone?

Dimitrios Mougiakakos, Everett H. Meyer, Georg Schett

Blood (2025) 145 (17): 1841–1849.

https://doi.org/10.1182/blood.2024025413

Published: 2025

Includes: Supplemental data

Journal Articles

The United Kingdom Infected Blood Inquiry: its findings and lessons for the future of transfusion

Michael F. Murphy, Susan R. Brailsford, David J. Roberts

Blood (2025) 145 (15): 1601–1609.

https://doi.org/10.1182/blood.2024025976

Published: 2025

Journal Articles

Introduction to a series of reflections on a quarter century of TKIs for CML

Brian J. Druker

Blood (2025) 145 (9): 909.

https://doi.org/10.1182/blood.2024026515

Published: 2025

Journal Articles

Hemoglobin-based transfusion strategies for cardiovascular and other diseases: restrictive, liberal, or neither?

Charles Natanson, Willard N. Applefeld, Harvey G. Klein

Blood (2024) 144 (20): 2075–2082.

https://doi.org/10.1182/blood.2024025927

Published: 2024

Journal Articles

Identifying disease-modifying potential in myelofibrosis clinical trials

David M. Ross, Steven W. Lane, Claire N. Harrison

Blood (2024) 144 (16): 1679–1688.

https://doi.org/10.1182/blood.2024024220

Published: 2024

Journal Articles

Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia

Richard I. Lewis, Alexander F. vom Stein, Michael Hallek

Blood (2024) 144 (6): 601–614.

https://doi.org/10.1182/blood.2023022861

Published: 2024

Journal Articles

Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms

Ronald P. Taylor, Margaret A. Lindorfer

Blood (2024) 144 (2): 137–144.

https://doi.org/10.1182/blood.2024024442

Published: 2024

Journal Articles

Smoldering multiple myeloma: taking the narrow over the wide path?

Herve Avet-Loiseau, Nizar J. Bahlis

Blood (2024) 143 (20): 2025–2028.

https://doi.org/10.1182/blood.2024023880

Published: 2024

Journal Articles

Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors

Lukas Veltmaat, Jorge Cortes

Blood (2024) 143 (10): 858–865.

https://doi.org/10.1182/blood.2023022403

Published: 2024

Journal Articles

Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action

Vijaya Raj Bhatt, Geoffrey L. Uy, Heidi D. Klepin

Blood (2024) 143 (6): 483–487.

https://doi.org/10.1182/blood.2023022611

Published: 2024

Includes: Supplemental data

Journal Articles

Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation

Jun Yong, Cheng-Hock Toh

Blood (2023) 142 (25): 2133–2145.

https://doi.org/10.1182/blood.2023021166

Published: 2023

Includes: Supplemental data

Journal Articles

The challenge of clinical end points in sickle cell disease

Kenneth I. Ataga

Blood (2023) 142 (24): 2047–2054.

https://doi.org/10.1182/blood.2023021220

Published: 2023

Journal Articles

Potential future direction of measurable residual disease evaluation in multiple myeloma

Mohamad Mohty, Hervé Avet-Loiseau, Florent Malard, Jean-Luc Harousseau

Blood (2023) 142 (18): 1509–1517.

https://doi.org/10.1182/blood.2023020284

Published: 2023

Includes: Supplemental data

Journal Articles

Mitigating inequity: ethically prioritizing patients for CAR T-cell therapy

Jennifer A. H. Bell, Gregory A. Jeffries, Christine I. Chen

Blood (2023) 142 (15): 1263–1270.

https://doi.org/10.1182/blood.2023020703

Published: 2023

Journal Articles

Novel developments in the prophylaxis and treatment of acute GVHD

Omer Jamy, Robert Zeiser, Yi-Bin Chen

Blood (2023) 142 (12): 1037–1046.

https://doi.org/10.1182/blood.2023020073

Published: 2023

Journal Articles

New ASH initiatives to improve patient care in the long-overlooked sickle cell disease

Venée N. Tubman, Narla Mohandas, Charles S. Abrams

Blood (2023) 142 (3): 230–234.

https://doi.org/10.1182/blood.2023020145

Published: 2023

Journal Articles

The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigators

Mohamed L. Sorror

Blood (2023) 141 (18): 2173–2186.

https://doi.org/10.1182/blood.2022017999

Published: 2023

Journal Articles

Introduction to a review series on germ line predisposition to hematologic malignancies: time to consider germ line testing

Mario Cazzola

Blood (2023) 141 (13): 1509–1512.

https://doi.org/10.1182/blood.2023019846

Published: 2023

Journal Articles

Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome

Michael S. Khodadoust, Eric Mou, Youn H. Kim

Blood (2023) 141 (7): 695–703.

https://doi.org/10.1182/blood.2020008241

Published: 2023

Journal Articles

Developing a classification of hematologic neoplasms in the era of precision medicine

Mario Cazzola, Laurie H. Sehn

Blood (2022) 140 (11): 1193–1199.

https://doi.org/10.1182/blood.2022015849

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CAR T cells in autoimmunity: game changer or stepping stone?

The United Kingdom Infected Blood Inquiry: its findings and lessons for the future of transfusion

Introduction to a series of reflections on a quarter century of TKIs for CML

Hemoglobin-based transfusion strategies for cardiovascular and other diseases: restrictive, liberal, or neither?

Identifying disease-modifying potential in myelofibrosis clinical trials

Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia

Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms

Smoldering multiple myeloma: taking the narrow over the wide path?

Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors

Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action

Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation

The challenge of clinical end points in sickle cell disease

Potential future direction of measurable residual disease evaluation in multiple myeloma

Mitigating inequity: ethically prioritizing patients for CAR T-cell therapy

Novel developments in the prophylaxis and treatment of acute GVHD

New ASH initiatives to improve patient care in the long-overlooked sickle cell disease

The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigators

Introduction to a review series on germ line predisposition to hematologic malignancies: time to consider germ line testing

Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome

Developing a classification of hematologic neoplasms in the era of precision medicine

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only